Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/01/1990 | EP0380155A1 8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives |
08/01/1990 | EP0380144A1 Process for producing optically active benzene-sulfonamide derivatives |
08/01/1990 | EP0380135A2 Use of 18-cyano-progesterone derivatives as aldosterone inhibitors |
08/01/1990 | EP0380084A2 Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions |
08/01/1990 | EP0380063A1 1,2-cyclohexylaminoaryl amides useful as analgesic agents |
08/01/1990 | EP0380048A2 Use of benzoyl urea derivatives as antiviral agents |
08/01/1990 | EP0380038A2 3-phenyl-5,6-dihydrobenz (C) - acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents |
08/01/1990 | EP0380036A2 Vaginal suppository |
08/01/1990 | EP0380023A1 Liquid pharmaceutical compositions containing a piperidinoalkanol antihistamine |
08/01/1990 | EP0380021A2 Stabilizing system for solid dosage forms |
08/01/1990 | EP0379990A1 Imidazolone derivatives with activity on central nervous system and antihypertensive activity, preparation methods thereof, and pharmaceutical compositions containing them |
08/01/1990 | EP0379981A1 Acetales of oxo-tetralines and of oxo-indanes |
08/01/1990 | EP0379979A1 Pyrazolopyridine compounds and processes for preparation thereof |
08/01/1990 | EP0379953A2 Substituted benzo[b]pyrans, process for their preparation, their use and pharmaceutical preparations based on these compounds |
08/01/1990 | EP0379936A2 Pyridoxal for use in enzyme deficiencies, and a diagnostic kit for their diagnosis |
08/01/1990 | EP0379933A2 Surface treatment system containing an antineoplastic agent, particularly 5-fluor uracil |
08/01/1990 | EP0379928A2 Aryl- and heteroarylethanol-pyridylalkylamines, process for their preparation and their use as performance stimulators by animals and as anti-adipositas agent |
08/01/1990 | EP0379753A1 N-acetyl glucosamine preparations for buccal use |
08/01/1990 | EP0379737A2 Dihydropyridine derivatives for the treatment of angiospasm |
08/01/1990 | EP0379708A1 Fungi strain Tolypocladiam varium and process for obtaining complexes of antibiotic cyclosporin and/or its components |
08/01/1990 | EP0379579A1 Pharmaceutical composition having improved releasability |
08/01/1990 | EP0379529A1 Antipsychotic gamma-carboline n-oxides |
08/01/1990 | EP0379500A1 Dermatological liposome composition containing pregnenolone. |
08/01/1990 | EP0379483A1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES AND 10-AZA, 10-OXA AND 10-THIA ANALOGUES |
08/01/1990 | EP0218689B1 Anthelmintic quinolinyl acylhydrazones and compositions |
08/01/1990 | EP0127677B1 Readily-absorpable fatty acid emulsions |
08/01/1990 | CN1044299A Serine analogs of bu-3608 antibiotics |
08/01/1990 | CN1044280A Cephalosporins derivatives and process for preparing them |
08/01/1990 | CN1044226A Process for production of transdermal therapeutical system comprising physostigmine as active component |
08/01/1990 | CN1044223A Packaged antibacterial antiplaque oral composition |
08/01/1990 | CN1009001B Method for selective methylation of erythromycin a derivatives |
08/01/1990 | CA2008908A1 Derivatives of platinum (ii) with polymethyl-siloxane, method for preparing same and antitumor agent based thereon |
08/01/1990 | CA2007643A1 Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination |
08/01/1990 | CA2007641A1 Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination |
07/31/1990 | WO1990008546A1 Oxoquinazoline derivatives used as xanthine oxidase inhibitors and their application in the case of ischemia |
07/31/1990 | US4945182 Oculoselective beta-blockers |
07/31/1990 | US4945181 Method for resolution of racemic thiamphenicol precursors and intermediates therefor |
07/31/1990 | US4945158 Antidiabetic phosphonates |
07/31/1990 | US4945115 Process for preparing ferulic acid |
07/31/1990 | US4945114 Therapeutic agents containing enantiomers of propafenone |
07/31/1990 | US4945108 Angucyclinones from streptomycetes, a process for the preparation thereof, and the use thereof |
07/31/1990 | US4945106 Prostaglandins |
07/31/1990 | US4945105 13-Halomilbemycin derivatives, their preparation and compositions containing them |
07/31/1990 | US4945103 Melatonin |
07/31/1990 | US4945102 Heterocyclic derivatives and radiosensitizing agents and antiviral agents comprising same as their active component |
07/31/1990 | US4945099 Leukotriene antagonist |
07/31/1990 | US4945097 Aryl-cycloalkyl-alkanolamines for treatment of neurotoxic injury |
07/31/1990 | US4945096 Treatment of a depressive state with 2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivates |
07/31/1990 | US4945095 Method for suppressing the immune response |
07/31/1990 | US4945094 Synergistic biologically active substances |
07/31/1990 | US4945093 Skin disorders, hair loss |
07/31/1990 | US4945092 Substituted 1-(oxopyrrolidinylalkanoyl)-piperazines useful as nootropics |
07/31/1990 | US4945090 Phenoxy-substituted beta-carboline derivatives, their production and their use as drugs |
07/31/1990 | US4945089 Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids |
07/31/1990 | US4945087 Sugar alcohol, anethole |
07/31/1990 | US4945085 Use of sucralfate for controlling emesis and/or diarrhea |
07/31/1990 | US4945084 Method and composition for topically treating anorectal or other dermal wounds |
07/31/1990 | US4945083 Safe oral folic-acid-containing vitamin preparation |
07/31/1990 | US4945081 Mycaminosyl tylonolide derivatives |
07/31/1990 | US4944946 Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) |
07/31/1990 | US4944945 Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) |
07/31/1990 | US4944941 Surfactants |
07/31/1990 | CA2026318A1 Use of oxoquinazoline derivatives |
07/31/1990 | CA2009044A1 An erosion-controlled release system for active agents and a process for its preparation |
07/31/1990 | CA2008772A1 Oral antifungal preventative, and method of use |
07/31/1990 | CA2008311A1 Carboxylic - and sulfonic acid amides |
07/31/1990 | CA1272202A1 Aminoalkyl-substituted cycloalkylamine platinum (ii) complexes |
07/31/1990 | CA1272201A1 Process for the manufacture of fluorinated benzyltriazoles |
07/31/1990 | CA1272198A1 5,14-dihydrobenz[5,6]isoindolo[2,1-b] isoquinoline-8,13-dione |
07/31/1990 | CA1272196A1 Tetraoxo compounds |
07/31/1990 | CA1272192A1 Metal complexes of bis-indole compounds and aqueous pharmaceutical compositions containing them |
07/31/1990 | CA1272188A1 Cephalosporin derivatives |
07/31/1990 | CA1272130A1 Oral compositions comprising salicylamides and zinc salts for the synergistic inhibition of dental plaque |
07/30/1990 | CA2007654A1 Heterocyclic derivatives |
07/30/1990 | CA2007525A1 Method for facilating dieting employing an ace inhibitor |
07/30/1990 | CA2007524A1 Method for treating addiction to a drug of abuse employing an ace inhibitor |
07/30/1990 | CA2007106A1 Dosage form for administering calcium antagonist |
07/27/1990 | CA2045180A1 Treatment of disease associated with hiv-infections |
07/27/1990 | CA2008732A1 Biocidal compositions and treatments |
07/27/1990 | CA2008683A1 Salts of phenyl piperazines |
07/26/1990 | WO1990008324A1 Cancer related haptoglobin (hpr) |
07/26/1990 | WO1990008153A1 Reagents for the preparation of 5'-biotinylated oligonucleotides |
07/26/1990 | WO1990008148A1 Bis-aza-bicyclic anxiolytic agents |
07/26/1990 | WO1990008146A1 Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides |
07/26/1990 | WO1990008145A1 Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles |
07/26/1990 | WO1990008144A1 Bis-aza-bicyclic anxiolytic agents |
07/26/1990 | WO1990008143A1 Fluorinated flavone acetic acid |
07/26/1990 | WO1990008135A1 Ethyl ester 6-bromine-5-hydroxy-4-dimethyl-aminomethyl-1-methyl-2-phenylthiomethyl indole-3-carboxylic acid hydrochloride monohydrate, method of obtaining it and a pharmaceutical preparation of antiviral, interferon inducing and immunomodulating action based on it |
07/26/1990 | WO1990008134A1 Chelating agent derivatives |
07/26/1990 | WO1990007952A1 Treatment methods and vaccines |
07/26/1990 | WO1990007936A1 Recombinant therapies for infection and hyperproliferative disorders |
07/26/1990 | WO1990007930A1 Use of dimethylpolysiloxane for treating disorders of the gastrointestinal tract |
07/26/1990 | WO1990007929A1 Site specific in-vivo activation of therapeutic drugs |
07/26/1990 | WO1990007927A1 Agent for treating prostatic hyperplasia |
07/26/1990 | WO1990007926A1 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines |
07/26/1990 | WO1990007876A1 Biological fluids purification systems |
07/26/1990 | WO1990006307A3 Antibacterial quinolone compounds |
07/26/1990 | WO1990003782A3 Finely divided solid crystalline powders via precipitation into an anti-solvent |
07/26/1990 | DE4001496A1 Niedrig dosierte zusammensetzung enthaltend benazepril und ein thiaziddiuretikum Low dose composition containing benazepril and a thiazide diuretic |
07/26/1990 | CA2008610A1 Imidazolone derivatives with activity on central nervous system and antihypertensive activity, preparation methods thereof, and pharmaceutical compositions containing them |